Silicate antibodies in Danish women with silicone breast implants

Rheumatology

Volumn 42, Issue 9, 2003, Pages 1032-1035

  Jensen, B ^a,b   Wiik, A ^c   Hechmann Wittrup, I ^a   Friis, S ^b   Shen, G Q ^d   Bliddal, H ^a   McLaughlin, J K ^e,f   Lykke Thomsen, B ^b   Danneskiold Samsoe B ^a   Olsen, J H ^b,f  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d Specialty Laboratories   (United States)

^e INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^f VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Breast implants; Silicate antibodies; Silicone; Symptom severity

Indexed keywords

ANTIBODY; SILICATE;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; BREAST AUGMENTATION; BREAST ENDOPROSTHESIS; BREAST REDUCTION; BREAST SURGERY; CLINICAL EXAMINATION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENMARK; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ETHNOLOGY; FEMALE; GENDER; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MUSCLE DISEASE; NONARTICULAR RHEUMATISM; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; SCORING SYSTEM; SILICONE PROSTHESIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADULT; AGED; ANTIBODIES; BREAST IMPLANTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; RHEUMATIC DISEASES; SILICATES; SILICONE GELS;

EID: 0141839024     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg282     Document Type: Article

References (26)

1. Tugwell P. Rheumatology: clinical case definitions/diagnoses and clinical associations. National Science Panel, USA 1998:1-74.
2. The Independent Review Group, Rogers J et al. Silicone gel breast implants: The report of the Independent Review Group Cambridge, UK: Jill Rogers Associates, 1998: Section 6.2.5.
3. Bondurant S, Ernster V, Herdman R. Safety of silicone breast implants. Committee on the Safety of Silicone Breast Implants, Division of Health Promotion and Disease Prevention. Institute of Medicine; National Academy of Sciences, Washington DC, USA 1999.
4. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective tissue diseases. N Engl J Med 2000;342:781- 90.
5. Wells KE, Roberts C, Daniels SM, Kearney RE, Cox CE. Psychological and rheumatic symptoms of women requesting silicone breast implant removal. Ann Plast Surg 1995; 34:572-7.
6. Soloman G. Clinical and laboratory profile in symptomatic women with silicone breast implants. Arthritis Rheum 1994;24(Suppl. 1):29-37.
7. Freundlich B, Altman C, Sandorfi N. A profile of symptomatic patients with silicone breast implants: A Sjögren's like syndrome. Semin Arthritis Rheum 1994;24:44-53.
8. Tugwell P, Wells G, Peterson J et al. Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national panel. Arthritis Rheum 2001;44:2477-84.
9. Wolf LE, Lappe M, Peterson RD, Ezrailson EG. Human immune response to polydimethylsiloxane (silicone): screening studies in a breast implant population. FASEB J 1993;7:1265-8.
10. Tenenbaum SA, Rice JC, Espinoza LR, Cuéllar ML, Plymale DR, Sander DM. Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet 1997; 349:449-54.
11. Goldblum RM, Pelley RP, O'Donell AA, Pyron D, Heggers JP. Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts. Lancet 1992;340:510-3.
12. Rohrich RJ, Hollier LH, Robinson JB. Determining the safety of the silicone envelope: in search of a silicone antibody. Plast Reconstr Surg 1996;98:455-8.
13. Rosenau B, Schneebaun AB, Schur PH. The development of an ELISA method for the detection of 'antibodies' to silicone. In: Compans RW, Cooper M, Koprowski H et al., eds. Immunology of silicones. Berlin: Springer, 1996:69-74.
14. Shen GQ, Ojo-Amaize EA, Agopian MS, Peter J. Silicate antibodies in women with silicone breast implants: Development of an assay for detection of humoral immunity. Clin Diagn Lab Immunol 1996;3:162-6.
15. Garrido L, Pfleiderer B, Papisov M, Ackerman JL. In vivo degradation of silicones. Magn Reson Med 1993; 29:839-43.
16. Pfleiderer B, Ackerman JL, Garrido L. Migration and biodegradation of free silicone from silicone gel-filled implants after long-term implantation. Magn Reson Med 1993;30:534-43.
17. Garrido L, Pfleiderer B, Jenkins BG, Hulka CA, Kopans DB. Migration and chemical modification of silicone in women with breast prostheses. Magn Reson Med 1994;31:328-30.
18. MacDonald P, Plavac N, Peters W, Lugowski S, Smith D. Failure of 29Si NMR to detect increased blood silicon levels in silicone breast implant recipients. Anal Chem 1995;67:3799-801.
19. Pfleiderer B, Moore A, Tokareva E, Ackerman JL, Garrido L. Biodegradation of polysiloxanes in lymph nodes of rats measured with 29 NMR. Biomaterials 1999;20:561-71.
20. Ojo-Amaize EA, Conte V, Lin HC, Brucker RF, Agopian MS, Peter JB. Silicone-specific blood lymphocyte response in women with silicone breast implants. Clin Diagn Lab Immunol 1994;1:689-95.
21. Jensen B, Bliddal H, Wittrup IH et al. Rheumatic manifestations in Danish women with silicone breast implants. Clin Rheumatol 2001;20:345-52.
22. Jensen B, Kjøller K, McLaughlin JK et al. Muscular rheumatism following breast surgery in Denmark. Clin Exp Rheumatol 2001;19:229.
23. Winther JF, Bach FW, Friis S et al. Neurologic disease among women with breast implants. Neurology 1998;50:951-5.
24. Marcovic BL, Abrambasic MD. Experimental chronic interstitial nephritis compared with endemic human neuropathy. J Pathol 1971;103:35-40.
25. Dobbie JW, Smith MJB. Urinary and serum silicon in normal and uraemic individuals. In: Evered D, O'Connor M, eds. Silicon biochemistry. Ciba Foundation Symposium 121. Chichester: Wiley, 1986:194-213.
26. Chandler PJ. The deposition of talc in patients with silicone gel-filled breast implants. Plast Reconstr Surg 1999; 104:661-8.